250255-72-2 Usage
Description
2-[2-(3-Oxobutyl)]-4-4-[4-(4-methoxyphenyl)-piperazin-1-yl]-phenyl-2,4-dihydro-[1,2,4-triazol-3-one (CAS# 250255-72-2) is a complex organic compound with a unique molecular structure. It is characterized as an off-white solid and is useful in various applications within the field of organic synthesis.
Uses
Used in Organic Synthesis:
2-[2-(3-Oxobutyl)]-4-4-[4-(4-methoxyphenyl)-piperazin-1-yl]-phenyl-2,4-dihydro-[1,2,4-triazol-3-one is used as a key intermediate in organic synthesis for the development of new chemical compounds. Its unique structure allows for the creation of a wide range of molecules with potential applications in various industries.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-[2-(3-Oxobutyl)]-4-4-[4-(4-methoxyphenyl)-piperazin-1-yl]-phenyl-2,4-dihydro-[1,2,4-triazol-3-one is used as a building block for the synthesis of new drug candidates. Its versatile chemical properties enable the design and development of innovative therapeutic agents with potential applications in treating various diseases and medical conditions.
Used in Chemical Research:
2-[2-(3-Oxobutyl)]-4-4-[4-(4-methoxyphenyl)-piperazin-1-yl]-phenyl-2,4-dihydro-[1,2,4-triazol-3-one is also utilized in chemical research for studying the properties and reactions of complex organic molecules. Its unique structure provides valuable insights into the behavior of similar compounds and contributes to the advancement of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 250255-72-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,0,2,5 and 5 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 250255-72:
(8*2)+(7*5)+(6*0)+(5*2)+(4*5)+(3*5)+(2*7)+(1*2)=112
112 % 10 = 2
So 250255-72-2 is a valid CAS Registry Number.
250255-72-2Relevant articles and documents
Synthesis and in vitro and in vivo antifungal activity of the hydroxy metabolites of saperconazole
Meerpoel, Lieven,Heeres, Jan,Backx, Leo J. J.,Van Der Veken, Louis J. E.,Hendrickx, Rob,Corens, David,De Groot, Alex,Leurs, Stef,Van Der Eycken, Luc,Weerts, Johan,Luyts, Paul,Van Gerven, Frans,Woestenborghs, Filip A. A.,Van Breda, Andre,Oris, Michel,Van Dorsselaer, Pascal,Willemsens, Gustaaf H. M.,Bellens, Danny,Marichal, Patrick J. M. G.,Vanden Bossche, Hugo F.,Odds, Frank C.
experimental part, p. 757 - 769 (2011/02/23)
Herein we describe the scalable diastereoselective and enantio-selective syntheses of eight enantiomers of hydroxy metabolites of saperconazole. The in vitro antifungal activity of the eight stereoisomers (compounds 1-8) was compared against a broad panel
